This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Raloxifene
EVISTA – Eli Lilly Canada Inc. (NOC Search)
Patents:
- 2101356: TEVA, APOTEX, NOVOPHARM, APOTEX, NOVOPHARM, APOTEX, TEVA, NOVOPHARM
- 2143263: NOVOPHARM
- 2158399: NOVOPHARM, APOTEX
- 2158400: APOTEX, NOVOPHARM, APOTEX, TEVA, TEVA, APOTEX, NOVOPHARM
- 2250191: NOVOPHARM, TEVA, NOVOPHARM, NOVOPHARM, APOTEX, TEVA, APOTEX
APOTEX
- Section 8 – T-656-09 (2009 FC 693)
- Appeal – A-108-13 – A-110-13 – A-172-11 (2011 FCA 358) – A-337-12 (2013 FCA 45) – A-338-12 – A-84-08 (2009 FCA 65, 2009 FCA 97)
- PM(NOC) – T-1364-05 (2008 FC 142) – T-1617-07 (2009 FC 320) – T-361-06
- Infringement – T-512-10
APOTEX, NOVOPHARM, TEVA
- Appeal – A-109-13
NOVOPHARM
- PM(NOC) – A-154-09 – T-1561-07 (2009 FC 301) – T-1562-07 (2009 FC 235) – T-1563-07 (2008 FC 513)
NOVOPHARM, APOTEX, TEVA
- Appeal – A-339-12
TEVA, APOTEX, NOVOPHARM
- Infringement – T-516-10
TEVA, NOVOPHARM
- Infringement – T-607-10
Return to the Patented Medicine Litigation page.